RPTX Repare Therapeutics | $1.37
+3.8% | 1/10/2025 | Downgraded by | Bloom Burton | Analyst D. Martin | Strong-Buy -> Hold | | Medium | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 1/10/2025 |
CYBN Cybin | $6.72
-1.3% | 5/2/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Cybin (OTCMKTS:CYBN) on 5/2/2024 |
RPTX Repare Therapeutics | $1.37
+3.8% | 4/19/2024 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 4/19/2024 |
RPTX Repare Therapeutics | $1.37
+3.8% | 2/13/2024 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 2/13/2024 |
MBX Microbix Biosystems | C$0.35
| 1/4/2024 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024 |
ABCL AbCellera Biologics | $2.61
+2.4% | 11/3/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023 |
MDP Medexus Pharmaceuticals | C$2.74
-2.5% | 6/26/2023 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023 |
RX BioSyent | C$10.90
-0.7% | 3/23/2023 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023 |
DOC CloudMD Software & Services | C$0.04
| 11/16/2022 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022 |
DOC CloudMD Software & Services | C$0.04
| 8/24/2022 | Downgraded by | Bloom Burton | Analyst P. Pandurangan | Buy -> Hold | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
MDNA Medicenna Therapeutics | C$1.16
+5.5% | 8/16/2022 | Target Lowered by | Bloom Burton | - | Buy | C$9.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022 |
MDNA Medicenna Therapeutics | C$1.16
+5.5% | 7/28/2022 | Reiterated by | Bloom Burton | - | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022 |
HLS HLS Therapeutics | C$4.24
-0.7% | 7/26/2022 | Reiterated by | Bloom Burton | - | Buy | C$22.00 | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022 |
MBX Microbix Biosystems | C$0.35
| 6/6/2022 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | N/A | View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022 |
GUD Knight Therapeutics | C$6.08
+1.5% | 3/28/2022 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | C$6.70 | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022 |
GUD Knight Therapeutics | C$6.08
+1.5% | 3/25/2022 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022 |
RX BioSyent | C$10.90
-0.7% | 3/10/2022 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022 |
DOC CloudMD Software & Services | C$0.04
| 12/22/2021 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Buy | | N/A | View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021 |
ABCL AbCellera Biologics | $2.61
+2.4% | 12/19/2021 | Reiterated by | Bloom Burton | Analyst A. Borovina | Buy | | Low | View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021 |
AUPH Aurinia Pharmaceuticals | $8.24
+1.5% | 10/1/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Hold | $23.00 | Medium | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021 |
RPTX Repare Therapeutics | $1.37
+3.8% | 9/30/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | $49.00 | Low | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/30/2021 |
MDNA Medicenna Therapeutics | C$1.16
+5.5% | 9/22/2021 | Initiated by | Bloom Burton | Analyst Prasath Pandurangan | Buy | C$11.00 | N/A | View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021 |
HLS HLS Therapeutics | C$4.24
-0.7% | 8/5/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021 |
VMD Viemed Healthcare | $7.07
+1.7% | 8/4/2021 | Upgraded by | Bloom Burton | Analyst P. Pandurangan | Accumulate -> Buy | | Low | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021 |
AUPH Aurinia Pharmaceuticals | $8.24
+1.5% | 5/7/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | High | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021 |
GUD Knight Therapeutics | C$6.08
+1.5% | 3/26/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021 |
RX BioSyent | C$10.90
-0.7% | 3/18/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021 |
MDP Medexus Pharmaceuticals | C$2.74
-2.5% | 2/23/2021 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 2/23/2021 |
EPIX ESSA Pharma | $1.82
+2.8% | 2/12/2021 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 2/12/2021 |
CRHM CRH Medical | $3.99
| 1/8/2021 | Downgraded by | Bloom Burton | Analyst D. Martin | Hold | $3.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 1/8/2021 |
CRHM CRH Medical | $3.99
| 12/23/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 12/23/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020 |
AUPH Aurinia Pharmaceuticals | $8.24
+1.5% | 11/3/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020 |
VMD Viemed Healthcare | $7.07
+1.7% | 10/19/2020 | Reiterated by | Bloom Burton | Analyst P. Pandurangan | Accumulate | | High | View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020 |
RPTX Repare Therapeutics | $1.37
+3.8% | 9/17/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of Repare Therapeutics (NASDAQ:RPTX) on 9/17/2020 |
HTL Hamilton Thorne | C$1.45
+4.3% | 8/21/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020 |
XENE Xenon Pharmaceuticals | $38.20
-0.4% | 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $25.00 | Medium | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020 |
CRH CRH | $95.41
+2.1% | 8/14/2020 | Reiterated by | Bloom Burton | - | Buy | | Low | View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020 |
CRHM CRH Medical | $3.99
| 8/13/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $4.00 | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/13/2020 |
CRHM CRH Medical | $3.99
| 8/12/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | High | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/12/2020 |
What President Trump’s Executive Order 14154 means for your money (Ad) Nearly $3 trillion disappeared from the stock market on Thursday morning.
According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard. But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi |
HLS HLS Therapeutics | C$4.24
-0.7% | 7/21/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020 |
GUD Knight Therapeutics | C$6.08
+1.5% | 6/29/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020 |
ZYME Zymeworks | $13.01
+2.5% | 6/14/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Zymeworks (NYSE:ZYME) on 6/14/2020 |
EPIX ESSA Pharma | $1.82
+2.8% | 5/24/2020 | Reiterated by | Bloom Burton | - | Buy | $9.00 | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/24/2020 |
CPH Cipher Pharmaceuticals | C$13.52
+1.0% | 5/8/2020 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Accumulate | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020 |
HLS HLS Therapeutics | C$4.24
-0.7% | 3/31/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020 |
RX BioSyent | C$10.90
-0.7% | 3/19/2020 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020 |
AUPH Aurinia Pharmaceuticals | $8.24
+1.5% | 3/19/2020 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | $23.00 | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/12/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019 |
GUD Knight Therapeutics | C$6.08
+1.5% | 10/22/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019 |
HLS HLS Therapeutics | C$4.24
-0.7% | 10/4/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019 |
AUPH Aurinia Pharmaceuticals | $8.24
+1.5% | 10/2/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019 |
RX BioSyent | C$10.90
-0.7% | 8/26/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019 |
CPH Cipher Pharmaceuticals | C$13.52
+1.0% | 8/12/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019 |
HLS HLS Therapeutics | C$4.24
-0.7% | 8/9/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019 |
CRHM CRH Medical | $3.99
| 8/1/2019 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 8/1/2019 |
MDP Medexus Pharmaceuticals | C$2.74
-2.5% | 7/3/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 7/3/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/16/2019 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 4/1/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019 |
HLS HLS Therapeutics | C$4.24
-0.7% | 3/22/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019 |
CPH Cipher Pharmaceuticals | C$13.52
+1.0% | 3/20/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019 |
CXRXF ADVANZ PHARMA | $17.06
| 3/15/2019 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | Low | View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019 |
GUD Knight Therapeutics | C$6.08
+1.5% | 11/9/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 3/26/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018 |
RX BioSyent | C$10.90
-0.7% | 3/22/2018 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018 |
EPI ESSA Pharma | C$8.20
+7.2% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018 |
EPIX ESSA Pharma | $1.82
+2.8% | 1/18/2018 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | High | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 1/18/2018 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/3/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017 |
HTL Hamilton Thorne | C$1.45
+4.3% | 10/25/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017 |
EPIX ESSA Pharma | $1.82
+2.8% | 9/12/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 9/12/2017 |
CPH Cipher Pharmaceuticals | C$13.52
+1.0% | 8/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017 |
CRHM CRH Medical | $3.99
| 7/14/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 7/14/2017 |
EPIX ESSA Pharma | $1.82
+2.8% | 5/18/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | Low | View details for Bloom Burton rating of ESSA Pharma (NASDAQ:EPIX) on 5/18/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/15/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017 |
CPH Cipher Pharmaceuticals | C$13.52
+1.0% | 5/12/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Hold -> Buy | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 5/9/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Hold | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017 |
CRHM CRH Medical | $3.99
| 2/24/2017 | Downgraded by | Bloom Burton | Analyst D. Martin | Buy -> Accumulate | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 2/24/2017 |
RX BioSyent | C$10.90
-0.7% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017 |
CPH Cipher Pharmaceuticals | C$13.52
+1.0% | 2/13/2017 | Reiterated by | Bloom Burton | Analyst D. Martin | Hold | | N/A | View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017 |
ABUS Arbutus Biopharma | $3.55
+4.1% | 1/9/2017 | Upgraded by | Bloom Burton | Analyst D. Martin | Accumulate -> Buy | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017 |
XENE Xenon Pharmaceuticals | $38.20
-0.4% | 12/22/2016 | Initiated by | Bloom Burton | - | Buy | $14.50 | N/A | View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016 |
ABUS Arbutus Biopharma | $3.55
+4.1% | 12/14/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016 |
GUD Knight Therapeutics | C$6.08
+1.5% | 11/10/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016 |
AUPH Aurinia Pharmaceuticals | $8.24
+1.5% | 11/4/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016 |
MRVFF Nuvo Pharmaceuticals | $0.98
| 11/2/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Accumulate | | N/A | View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016 |
CRHM CRH Medical | $3.99
| 10/28/2016 | Reiterated by | Bloom Burton | Analyst D. Martin | Buy | | N/A | View details for Bloom Burton rating of CRH Medical (NYSEAMERICAN:CRHM) on 10/28/2016 |
ACHV Achieve Life Sciences | $2.60
+7.4% | 5/3/2013 | Target Raised by | Bloom Burton | - | Buy | $4,000.00 -> $5,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013 |
ACHV Achieve Life Sciences | $2.60
+7.4% | 3/8/2013 | Target Raised by | Bloom Burton | - | | $3,600.00 -> $4,000.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013 |
ONC Oncolytics Biotech | C$0.77
-6.1% | 12/18/2012 | Downgraded by | Bloom Burton | - | Buy -> Hold | | N/A | View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012 |
THTX Theratechnologies | $2.84
-1.0% | 6/25/2012 | Downgraded by | Bloom Burton | - | Hold -> Sell | $2.50 -> $0.75 | N/A | View details for Bloom Burton rating of Theratechnologies (NASDAQ:THTX) on 6/25/2012 |
The collapse has already started (Ad) The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim Plaehn reveals how the 2025 trade war is quietly eroding dividend income — and which U.S.-focused stocks are still raising payouts. Watch the 2025 Trade War dividend protection briefing now |
ACHV Achieve Life Sciences | $2.60
+7.4% | 5/4/2012 | Target Lowered by | Bloom Burton | - | Buy | $3,800.00 -> $3,600.00 | N/A | View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012 |
